I

InBody Co Ltd
KOSDAQ:041830

Watchlist Manager
InBody Co Ltd
KOSDAQ:041830
Watchlist
Price: 29 500 KRW -2.48% Market Closed
Market Cap: ₩397.7B

InBody Co Ltd
Cash & Cash Equivalents

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

InBody Co Ltd
Cash & Cash Equivalents Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash & Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
I
InBody Co Ltd
KOSDAQ:041830
Cash & Cash Equivalents
₩52.4B
CAGR 3-Years
34%
CAGR 5-Years
25%
CAGR 10-Years
25%
I
I Sens Inc
KOSDAQ:099190
Cash & Cash Equivalents
₩45B
CAGR 3-Years
-10%
CAGR 5-Years
8%
CAGR 10-Years
7%
C
Classys Inc
KOSDAQ:214150
Cash & Cash Equivalents
₩37.5B
CAGR 3-Years
13%
CAGR 5-Years
-10%
CAGR 10-Years
64%
W
Won Tech Co Ltd
KOSDAQ:336570
Cash & Cash Equivalents
₩32.8B
CAGR 3-Years
445%
CAGR 5-Years
90%
CAGR 10-Years
N/A
V
Viol Co Ltd
KOSDAQ:335890
Cash & Cash Equivalents
₩35.1B
CAGR 3-Years
79%
CAGR 5-Years
77%
CAGR 10-Years
N/A
S
Seers Technology Co Ltd
KOSDAQ:458870
Cash & Cash Equivalents
₩10.8B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

InBody Co Ltd
Glance View

Market Cap
397.7B KRW
Industry
Health Care

InBody Co., Ltd. engages in the manufacture and sale of medical equipment. The company is headquartered in Seoul, Seoul. The company went IPO on 2000-12-14. The firm mainly produces body composition analyzers under the brand names of InBody and Lookin’Body. The firm mainly produces body composition analyzers under the brand name InBody and Lookin’Body. Its InBody series products include InBody720, InBody520, InBody230, InBody R20, InBody S20, InBody S10 and InBody J10. Its Lookin' series products include Lookin’Body3.0 and Lookin’Body Basic, which are used for measuring proteins, minerals, fats, moistures and others. The company also provides body mass index (BMI) measuring devices under the brand name of BSM. The firm distributes its products within domestic market and to overseas markets.

Intrinsic Value
36 034.47 KRW
Undervaluation 18%
Intrinsic Value
Price ₩29 500
I

See Also

What is InBody Co Ltd's Cash & Cash Equivalents?
Cash & Cash Equivalents
52.4B KRW

Based on the financial report for Dec 31, 2025, InBody Co Ltd's Cash & Cash Equivalents amounts to 52.4B KRW.

What is InBody Co Ltd's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 10Y
25%

Over the last year, the Cash & Cash Equivalents growth was 69%. The average annual Cash & Cash Equivalents growth rates for InBody Co Ltd have been 34% over the past three years , 25% over the past five years , and 25% over the past ten years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett